VANGUARD GROUP INC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,424,912
-62.4%
1,630,688
+1.5%
0.00%
Q2 2023$17,080,114
+81.1%
1,606,784
+41.9%
0.00%
Q1 2023$9,429,452
-36.2%
1,131,987
-29.3%
0.00%
Q4 2022$14,786,876
-43.8%
1,602,045
-21.8%
0.00%
-100.0%
Q3 2022$26,295,000
-0.2%
2,047,904
+2.7%
0.00%0.0%
Q2 2022$26,354,000
-35.4%
1,995,033
+2.9%
0.00%0.0%
Q1 2022$40,824,000
-11.0%
1,939,390
+1.4%
0.00%0.0%
Q4 2021$45,873,000
-2.4%
1,912,182
+3.5%
0.00%0.0%
Q3 2021$47,003,000
-19.7%
1,847,615
+6.3%
0.00%0.0%
Q2 2021$58,527,000
-9.3%
1,738,802
+4.7%
0.00%
-50.0%
Q1 2021$64,514,000
-35.1%
1,661,011
+3.4%
0.00%
-33.3%
Q4 2020$99,475,000
+127.4%
1,606,268
+23.0%
0.00%
+200.0%
Q3 2020$43,737,000
+43.6%
1,305,960
+2.2%
0.00%0.0%
Q2 2020$30,462,000
+67.1%
1,278,341
+60.6%
0.00%0.0%
Q1 2020$18,229,000
-16.7%
795,990
+3.0%
0.00%0.0%
Q4 2019$21,886,000
+51.2%
772,804
+14.7%
0.00%0.0%
Q3 2019$14,476,000
+396.3%
673,584
+573.6%
0.00%
Q2 2019$2,917,000100,0000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders